{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:19:42Z","timestamp":1791897582417,"version":"4.3.4"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T00:00:00Z","timestamp":1557360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurosurg.","NEUROS"],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Fluorescence-guided surgery (FGS) can improve extent of resection in gliomas. Tozuleristide (BLZ-100), a near-infrared imaging agent composed of the peptide chlorotoxin and a near-infrared fluorophore indocyanine green, is a candidate molecule for FGS of glioma and other tumor types.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To perform a phase 1 dose-escalation study to characterize the safety, pharmacokinetics, and fluorescence imaging of tozuleristide in adults with suspected glioma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>Patients received a single intravenous dose of tozuleristide 3 to 29 h before surgery. Fluorescence images of tumor and cavity in Situ before and after resection and of excised tissue ex Vivo were acquired, along with safety and pharmacokinetic measures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>A total of 17 subjects received doses between 3 and 30 mg. No dose-limiting toxicity was observed, and no reported adverse events were considered related to tozuleristide. At doses of 9 mg and above, the terminal serum half-life for tozuleristide was approximately 30 min. Fluorescence signal was detected in both high- and low-grade glial tumors, with high-grade tumors generally showing greater fluorescence intensity compared to lower grade tumors. In high-grade tumors, signal intensity increased with increased dose levels of tozuleristide, regardless of the time of dosing relative to surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>These results support the safety of tozuleristide at doses up to 30 mg and suggest that tozuleristide imaging may be useful for FGS of gliomas.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/neuros\/nyz125","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T17:07:13Z","timestamp":1554484033000},"page":"E641-E649","source":"Crossref","is-referenced-by-count":109,"title":["Phase 1 Safety, Pharmacokinetics, and Fluorescence Imaging Study of Tozuleristide (BLZ-100) in Adults With Newly Diagnosed or Recurrent Gliomas"],"prefix":"10.1227","volume":"85","author":[{"given":"Chirag G","family":"Patil","sequence":"first","affiliation":[{"name":"Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G","family":"Walker","sequence":"additional","affiliation":[{"name":"NEWRO Foundation, Brisbane, Australia"},{"name":"Dermatology Research Centre, The University of Queensland, The University of Queensland Diamantina Institute, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis M","family":"Miller","sequence":"additional","affiliation":[{"name":"Blaze Bioscience, Inc, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod","family":"Butte","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Morrison","sequence":"additional","affiliation":[{"name":"NEWRO Foundation, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S","family":"Kittle","sequence":"additional","affiliation":[{"name":"Blaze Bioscience, Inc, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey J","family":"Hansen","sequence":"additional","affiliation":[{"name":"Blaze Bioscience, Inc, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlin L","family":"Nufer","sequence":"additional","affiliation":[{"name":"Dermatology Research Centre, The University of Queensland, The University of Queensland Diamantina Institute, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly A","family":"Byrnes-Blake","sequence":"additional","affiliation":[{"name":"Northwest PK Solutions, LLC, Sultan, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miko","family":"Yamada","sequence":"additional","affiliation":[{"name":"Dermatology Research Centre, The University of Queensland, The University of Queensland Diamantina Institute, Brisbane, Australia"},{"name":"Future Industries Institute, University of South Australia, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynlee L","family":"Lin","sequence":"additional","affiliation":[{"name":"Dermatology Research Centre, The University of Queensland, The University of Queensland Diamantina Institute, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Pham","sequence":"additional","affiliation":[{"name":"Dermatology Research Centre, The University of Queensland, The University of Queensland Diamantina Institute, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Perry","sequence":"additional","affiliation":[{"name":"Blaze Bioscience, Inc, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Parrish-Novak","sequence":"additional","affiliation":[{"name":"Blaze Bioscience, Inc, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ishak","sequence":"additional","affiliation":[{"name":"Blaze Bioscience, Inc, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarl","family":"Prow","sequence":"additional","affiliation":[{"name":"Dermatology Research Centre, The University of Queensland, The University of Queensland Diamantina Institute, Brisbane, Australia"},{"name":"Future Industries Institute, University of South Australia, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Black","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam N","family":"Mamelak","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,10]]},"reference":[{"issue":"11","key":"bib1-20231011","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jamaoncol.2016.1373","article-title":"Association of the extent of resection with survival in Glioblastoma","volume":"2","author":"Brown","year":"2016","journal-title":"JAMA Oncol"},{"issue":"8","key":"bib2-20231011","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1200\/JCO.2007.13.9337","article-title":"Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas","volume":"26","author":"Smith","year":"2008","journal-title":"J Clin Oncol"},{"issue":"1","key":"bib3-20231011","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/neuonc\/nov145","article-title":"Clinical benefit from resection of recurrent glioblastomas: results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection","volume":"18","author":"Ringel","year":"2016","journal-title":"Neuro Oncol"},{"issue":"274","key":"bib4-20231011","doi-asserted-by":"crossref","first-page":"274ra19","DOI":"10.1126\/scitranslmed.aaa2384","article-title":"Intraoperative brain cancer detection with Raman spectroscopy in humans","volume":"7","author":"Jermyn","year":"2015","journal-title":"Sci Transl Med"},{"issue":"2","key":"bib5-20231011","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11060-016-2171-4","article-title":"Technical principles in glioma surgery and preoperative considerations","volume":"130","author":"Krivosheya","year":"2016","journal-title":"J Neurooncol"},{"issue":"5","key":"bib6-20231011","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/00006123-200011000-00008","article-title":"Quantification of, visualization of, and compensation for brain shift using intraoperative magnetic resonance imaging","volume":"47","author":"Nimsky","year":"2000","journal-title":"Neurosurgery"},{"issue":"3","key":"bib7-20231011","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/PPO.0000000000000113","article-title":"Image-guided tumor resection","volume":"21","author":"Parrish-Novak","year":"2015","journal-title":"Cancer J"},{"key":"bib8-20231011","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fsurg.2016.00055","article-title":"Intraoperative fluorescence imaging for personalized brain tumor resection: current state and future directions","volume":"3","author":"Belykh","year":"2016","journal-title":"Front Surg"},{"issue":"1","key":"bib9-20231011","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/bip.22748","article-title":"Chlorotoxin: structure, activity, and potential uses in cancer therapy","volume":"106","author":"Ojeda","year":"2016","journal-title":"Biopolymers"},{"issue":"4","key":"bib10-20231011","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3390\/toxins7041079","article-title":"Chlorotoxin: a helpful natural scorpion peptide to diagnose glioma and fight tumor invasion","volume":"7","author":"Dardevet","year":"2015","journal-title":"Toxins"},{"issue":"suppl","key":"bib11-20231011","doi-asserted-by":"crossref","first-page":"abstr e14507","DOI":"10.1200\/jco.2009.27.15_suppl.e14507","article-title":"A phase I evaluation of intravenous (IV) 131 I-chlorotoxin delivery to solid peripheral and intracranial tumors","volume":"27","author":"Gribbin","year":"2009","journal-title":"J Clin Oncol"},{"issue":"4","key":"bib12-20231011","first-page":"580","article-title":"Imaging glioma extent with 131I-TM-601","volume":"46","author":"Hockaday","year":"2005","journal-title":"J Nucl Med"},{"issue":"22","key":"bib13-20231011","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1200\/JCO.2005.05.4569","article-title":"Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma","volume":"24","author":"Mamelak","year":"2006","journal-title":"J Clin Oncol"},{"issue":"2","key":"bib14-20231011","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ab.2013.05.013","article-title":"Characterization of IRDye 800CW chlorotoxin as a targeting agent for brain tumors","volume":"440","author":"Kovar","year":"2013","journal-title":"Anal Biochem"},{"issue":"38","key":"bib15-20231011","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.2174\/138161211798999375","article-title":"In Vivo bio-imaging using chlorotoxin-based conjugates","volume":"17","author":"Stroud","year":"2011","journal-title":"Curr Pharm Des"},{"issue":"14","key":"bib16-20231011","doi-asserted-by":"crossref","first-page":"6882","DOI":"10.1158\/0008-5472.CAN-06-3948","article-title":"Tumor Paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci","volume":"67","author":"Veiseh","year":"2007","journal-title":"Cancer Res"},{"issue":"5","key":"bib17-20231011","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2310\/7290.2010.00034","article-title":"Image-guided surgery using invisible near-infrared light: fundamentals of clinical translation","volume":"9","author":"Gioux","year":"2010","journal-title":"Mol Imag"},{"key":"bib18-20231011","doi-asserted-by":"crossref","first-page":"940585","DOI":"10.1155\/2012\/940585","article-title":"A review of indocyanine green fluorescent imaging in surgery","volume":"2012","author":"Alander","year":"2012","journal-title":"Int J Biomed Imag"},{"issue":"2","key":"bib19-20231011","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/1091581817697685","article-title":"Nonclinical profile of BLZ-100, a tumor-targeting fluorescent imaging agent","volume":"36","author":"Parrish-Novak","year":"2017","journal-title":"Int J Toxicol"},{"issue":"4","key":"bib20-20231011","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/jamaoto.2015.3617","article-title":"Fluorescence identification of head and neck squamous cell carcinoma and high-risk oral dysplasia with BLZ-100, a Chlorotoxin-Indocyanine green conjugate","volume":"142","author":"Baik","year":"2016","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"20","key":"bib21-20231011","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1158\/0008-5472.CAN-15-0471","article-title":"Preclinical validation of the utility of BLZ-100 in providing fluorescence contrast for imaging spontaneous solid tumors","volume":"75","author":"Fidel","year":"2015","journal-title":"Cancer Res"},{"issue":"2","key":"bib22-20231011","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.3171\/2013.11.FOCUS13497","article-title":"Near-infrared imaging of brain tumors using the Tumor Paint BLZ-100 to achieve near-complete resection of brain tumors","volume":"36","author":"Butte","year":"2014","journal-title":"Neurosurg Focus"},{"issue":"5","key":"bib23-20231011","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1177\/1553350612468962","article-title":"An experimental study to evaluate the Fluobeam 800 imaging system for fluorescence-guided lymphatic imaging and sentinel node biopsy","volume":"20","author":"Hirche","year":"2013","journal-title":"Surg Innov"},{"issue":"9","key":"bib24-20231011","first-page":"e2014","article-title":"Fluorescence-guided tumor visualization using the Tumor Paint BLZ-100","volume":"6","author":"Kittle","year":"2014","journal-title":"Cureus"},{"issue":"2","key":"bib25-20231011","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3171\/2013.9.JNS13843","article-title":"Risk factors and outcomes associated with surgical site infections after craniotomy or craniectomy","volume":"120","author":"Chiang","year":"2014","journal-title":"J Neurosurg"},{"issue":"suppl_4","key":"bib26-20231011","doi-asserted-by":"crossref","first-page":"iv54","DOI":"10.1093\/neuonc\/nox083.224","article-title":"TRTH-12. Phase 1 safety, pharmacokinetic and imaging study of BLZ-100 tumor paint in pediatric brain tumor patients","volume":"19","author":"Lee","year":"2017","journal-title":"Neuro Oncol"},{"issue":"2","key":"bib27-20231011","doi-asserted-by":"crossref","first-page":"C361","DOI":"10.1152\/ajpcell.1993.264.2.C361","article-title":"Purification and characterization of chlorotoxin, a chloride channel ligand from the venom of the scorpion","volume":"264","author":"DeBin","year":"1993","journal-title":"Am J Physiol Cell Physiol"},{"issue":"6","key":"bib28-20231011","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1074\/jbc.M205662200","article-title":"Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2","volume":"278","author":"Deshane","year":"2003","journal-title":"J Biol Chem"},{"issue":"7","key":"bib29-20231011","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1074\/jbc.M109.066092","article-title":"Annexin A2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects","volume":"285","author":"Kesavan","year":"2010","journal-title":"J Biol Chem"},{"issue":"1","key":"bib30-20231011","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1479-5876-6-80","article-title":"Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells","volume":"6","author":"Sarin","year":"2008","journal-title":"J Transl Med"},{"issue":"6","key":"bib31-20231011","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1227\/NEU.0000000000001450","article-title":"Intraoperative near-infrared optical imaging can localize gadolinium-enhancing gliomas during surgery","volume":"79","author":"Lee","year":"2016","journal-title":"Neurosurgery"},{"issue":"5","key":"bib32-20231011","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S1470-2045(06)70665-9","article-title":"Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial","volume":"7","author":"Stummer","year":"2006","journal-title":"Lancet Oncol"},{"issue":"5","key":"bib33-20231011","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.cbpa.2003.08.007","article-title":"In Vivo near-infrared fluorescence imaging","volume":"7","author":"Frangioni","year":"2003","journal-title":"Curr Opin Chem Biol"},{"issue":"5","key":"bib1a-20231011","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S1470-2045(06)70665-9","article-title":"Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: A randomized controlled multicenter phase III trial","volume":"7","author":"Stummer","year":"2006","journal-title":"Lancet Oncol"},{"issue":"1","key":"bib2a-20231011","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3171\/2016.7.JNS16232","article-title":"Aggressive resection at the infiltrative margins of glioblastoma facilitated by intraoperative fluorescein guidance","volume":"127","author":"Neira","year":"2017","journal-title":"J Neurosurg"}],"container-title":["Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neurosurgery\/advance-article-pdf\/doi\/10.1093\/neuros\/nyz125\/28566862\/nyz125.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ovid.com\/10.1093\/neuros\/nyz125","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:45:41Z","timestamp":1786121141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1093\/neuros\/nyz125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,9]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1093\/neuros\/nyz125","relation":{},"ISSN":["0148-396X","1524-4040"],"issn-type":[{"value":"0148-396X","type":"print"},{"value":"1524-4040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,9]]}}}